An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform - PubMed (original) (raw)
. 2006 Dec 11;45(48):8149-52.
doi: 10.1002/anie.200602251.
Affiliations
- PMID: 17099918
- DOI: 10.1002/anie.200602251
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform
Vaishali Bagalkot et al. Angew Chem Int Ed Engl. 2006.
No abstract available
Similar articles
- Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ, Meng L, Chen T, Zhang Y, Sefah K, Tan W. Donovan MJ, et al. Methods Mol Biol. 2011;764:141-52. doi: 10.1007/978-1-61779-188-8_9. Methods Mol Biol. 2011. PMID: 21748638 - Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
Taghdisi SM, Abnous K, Mosaffa F, Behravan J. Taghdisi SM, et al. J Drug Target. 2010 May;18(4):277-81. doi: 10.3109/10611860903434050. J Drug Target. 2010. PMID: 19943768 - The development and testing of aptamers for cancer.
Barbas AS, White RR. Barbas AS, et al. Curr Opin Investig Drugs. 2009 Jun;10(6):572-8. Curr Opin Investig Drugs. 2009. PMID: 19513946 Review. - Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Bidwell GL 3rd, Fokt I, Priebe W, Raucher D. Bidwell GL 3rd, et al. Biochem Pharmacol. 2007 Mar 1;73(5):620-31. doi: 10.1016/j.bcp.2006.10.028. Epub 2006 Nov 10. Biochem Pharmacol. 2007. PMID: 17161827 - Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X, Zhao Q, Qiu L. Li X, et al. J Control Release. 2013 Oct 28;171(2):152-62. doi: 10.1016/j.jconrel.2013.06.006. Epub 2013 Jun 15. J Control Release. 2013. PMID: 23777885 Review.
Cited by
- DNA Polyplexes as Combinatory Drug Carriers of Doxorubicin and Cisplatin: An in Vitro Study.
Kang HC, Cho H, Bae YH. Kang HC, et al. Mol Pharm. 2015 Aug 3;12(8):2845-57. doi: 10.1021/mp500873k. Epub 2015 Jul 13. Mol Pharm. 2015. PMID: 26132975 Free PMC article. - pH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma.
Li Y, Yue S, Cao J, Zhu C, Wang Y, Hai X, Song W, Bi S. Li Y, et al. Theranostics. 2020 Jul 9;10(18):8250-8263. doi: 10.7150/thno.45803. eCollection 2020. Theranostics. 2020. PMID: 32724469 Free PMC article. - A unique aptamer-drug conjugate for targeted therapy of multiple myeloma.
Wen J, Tao W, Hao S, Iyer SP, Zu Y. Wen J, et al. Leukemia. 2016 Apr;30(4):987-91. doi: 10.1038/leu.2015.216. Epub 2015 Aug 5. Leukemia. 2016. PMID: 26242462 No abstract available. - Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate.
Xiang W, Peng Y, Zeng H, Yu C, Zhang Q, Liu B, Liu J, Hu X, Wei W, Deng M, Wang N, Liu X, Xie J, Hou W, Tang J, Long Z, Wang L, Liu J. Xiang W, et al. Biomater Res. 2022 Dec 5;26(1):74. doi: 10.1186/s40824-022-00328-9. Biomater Res. 2022. PMID: 36471380 Free PMC article. - Structural DNA nanotechnology at the nexus of next-generation bio-applications: challenges and perspectives.
Kosara S, Singh R, Bhatia D. Kosara S, et al. Nanoscale Adv. 2023 Dec 19;6(2):386-401. doi: 10.1039/d3na00692a. eCollection 2024 Jan 16. Nanoscale Adv. 2023. PMID: 38235105 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources